α -Pyrrolidinoheptaphenone
Appearance
![]() | |
Clinical data | |
---|---|
Other names | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H25NO |
Molar mass | 259.393 g·mol−1 |
3D model (JSmol) | |
| |
|
In the United States,
See also[edit]
References[edit]
- ^ Minakata K, Yamagishi I, Nozawa H, Hasegawa K, Wurita A, Gonmori K, et al. (2015). "Determination of new pyrrolidino cathinone derivatives, PVT, F-PVP, MPHP, PV8, PV9 and F-PV9, in human blood by MALDI-Q-TOF mass spectrometry". Forensic Toxicology. 33: 148–154. doi:10.1007/s11419-014-0248-3. S2CID 8271553.
- ^ Uchiyama N, Matsuda S, Kawamura M, Shimokawa Y, Kikura-Hanajiri R, Aritake K, et al. (October 2014). "Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog,
α -PHPP andα -POP, with 11 newly distributed designer drugs in illegal products". Forensic Science International. 243: 1–13. doi:10.1016/j.forsciint.2014.03.013. PMID 24769262. - ^ "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone,
α -PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α -PVP in Schedule I". Drug Enforcement Administration. Archived from the original on 2021-04-30. Retrieved 2019-07-30.